Last updated on February 2018

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lymphoma
  • Age: Between 18 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Histological Diagnosis of NHL- DLBCL.
  • Eligible for RT after R-CHOP.
  • ECOG 0-3.
  • 18 - 65 years.
  • Stage I-IV.
  • Patients should receive at least 4 cycles of R-CHOP chemotherapy.
  • Patients with all extranodal disease except the ones mentioned in the exclusion criteria.
  • Able to understand and willing to provide informed consent for participation in the trial.

Exclusion Criteria:

  • HIV positive status.
  • Relapse or progression of disease during chemotherapy.
  • Prior history of chemotherapy
  • Prior history of radiotherapy.
  • Systemic lymphomas with CNS involvement.
  • Primary extranodal Testicular Lymphomas.
  • Primary extranodal central nervous system (CNS) Lymphomas.
  • Primary extranodal Stomach DLBCL
  • Primary extranodal Intestinal DLBCL
  • Patients >3 extranodal sites

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.